How is the FDA planning to regulate changing AI medical devices?

The article says the core debate is whether the FDA can apply its 1976 medical device framework to AI systems that learn and change after launch. It argues the real issue is how much post-market product change regulators will tolerate before requiring heavier review, with concerns that fear-driven regulation could slow useful adoption.